Conway Capital Management, Inc. Royalty Pharma PLC Transaction History

Conway Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 02, 2024	SELL	$29.6 - $36.56 $289,044 - $357,008	-9,765 Closed	0 $0
Q1 2023 Dec 02, 2024	SELL	$32.77 - $39.4 $27,494 - $33,056	-839 Reduced 7.91%	9,765 $352 Million
Q4 2022 Dec 02, 2024	BUY	$39.17 - $44.04 $391 - $440	10 Added 0.09%	10,604 $419 Million
Q3 2022 Dec 02, 2024	SELL	$39.88 - $44.65 $9,611 - $10,760	-241 Reduced 2.22%	10,594 $426 Million
Q2 2022 Dec 02, 2024	BUY	$37.53 - $44.22 $375 - $442	10 Added 0.09%	10,835 $456 Million
Q1 2022 Dec 02, 2024	BUY	$37.46 - $42.44 $405,504 - $459,413	10,825 New	10,825 $422 Million

414

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Conway Capital Management, Inc. with notifications on news.